";s:4:"text";s:4292:" approximately 1/10 the dose.Chief of the Division of Gastroenterology and HepatologyExplore additional results from the VEMLIDY pivotal clinical trials in this presentation by Dr. Brown.Chief of the Division of Gastroenterology and HepatologySupport your chronic hepatitis B patients by sharing
If appropriate, resumption of anti-hepatitis B therapy may be warranted. What should I tell my healthcare provider before taking VEMLIDY? endobj
<>
<>
VEMLIDY from Week 96 through Week 120 (n = 361 remained on VEMLIDY; n = 180 switched from TDF to VEMLIDY at Week 96). full prescribing information baraclude ® (entecavir) 1 warning: severe acute exacerbations of hepatitis b, patients co-infected with hiv and hbv, and lactic acidosis and hepatomegaly endobj
1.4 Limitation of Use If CIALIS is used with finasteride to initiate BPH treatment, such use is recommended for up to 26 weeks because the incremental benefit of CIALISdecreasesfrom 4 weeks until 26 weeks,and the incremental benefit of CIALIS beyond 26 weeks is unknown [see Clinical Studies (14.3)].
1 0 obj
Generic Vemlidy Availability. <>/Metadata 2000 0 R/ViewerPreferences 2001 0 R>>
<>/ExtGState<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/MediaBox[ 0 0 612 792] /Contents 4 0 R/Group<>/Tabs/S/StructParents 0>>
States only. Vemlidy is indicated for the treatment of chronic hepatitis B virus (HBV) infection in adults with compensated liver disease [see Clinical Studies (14)]. VEMLIDY 25 mg demonstrates more efficient delivery of tenofovir to the hepatocytes vs TDF 300 mg, at VEMP0351 04/20 endobj
What is the most important information I should know about VEMLIDY? The information contained on this site is intended for audiences in the United VEMLIDY, the VEMLIDY Logo, GSI, ADVANCING ACCESS, GILEAD and the GILEAD Logo If you have HIV and take VEMLIDY, the HIV virus may develop resistance and become harder to treat. All other VEMLIDY can cause serious side effects, including: Worsening of hepatitis B infection. Vemlidy comes in a 25mg tablet that is usually taken once daily with food. Your healthcare provider may test you for HIV infection before starting VEMLIDY. %PDF-1.7
4 0 obj
adults with compensated liver disease. Based on the Week 96 analysis, the most common adverse reaction (all Grades) reported in at least 10% of subjects in the VEMLIDY group was headache. Antiviral efficacy proven in noninferiority trials with TDF, with safety demonstrated in renal and bone
%����
regulatory control, legal requirements, and/or medical practices may vary in 2 0 obj
Vemlidy is a brand name of tenofovir alafenamide, approved by the FDA in the following formulation(s):. Click "Continue" to leave this site and come back to visit us another time. Discontinuation of anti-hepatitis B therapy, including VEMLIDY, may result in severe acute exacerbations of hepatitis B. Hepatic function should be monitored closely with both clinical and laboratory follow-up for at least several months in patients who discontinue anti-hepatitis B therapy, including VEMLIDY. x��][o�8�~o��_�E���`0����^tg��{�,&����K^Y��S�7VQ�e��;N�w��ǖe},�X7V��?��b��+����?VU:�g����X��|��*;�Mg�E~~�y��҇,�d�?���K���o�P�F�`e���?���o.Foߜ�猫�M߾��>�q�{!\�d�1-�}?�Gl�V�d3�ן~z��W��A�^�?��78�����W�����������͵���}�Aߕ�1á:�6��D��$������H�Į? Your hepatitis B (HBV) infection may become worse (flare-up) if you take VEMLIDY and then stop taking it.